Editas Medicine
EDIT
229 hedge funds and large institutions have $1.35B invested in Editas Medicine in 2019 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 67 increasing their positions, 47 reducing their positions, and 20 closing their positions.
220% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 20
43% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 47
32% more capital invested
Capital invested by funds: $1.02B → $1.35B (+$331M)
22% more funds holding
Funds holding: 187 → 229 (+42)
9% more call options, than puts
Call options by funds: $32M | Put options by funds: $29.3M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.66% less ownership
Funds ownership: 90.87% → 89.21% (-1.7%)
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$10.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.22M |
| 3 |
Two Sigma Investments
New York
|
+$5.11M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$4.16M |
| 5 |
BlackRock
New York
|
+$2.92M |
Top Sellers
| 1 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
-$12.8M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$12.1M |
| 3 |
CC
Casdin Capital
New York
|
-$9.44M |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.91M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.51M |
EDIT Hedge Fund Activity: Q4 2019 in Review
229 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2019, worth a combined $1.35B — up 32% from $1.02B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new EDIT positions and 20 closed out — a net gain of 44 holders — while 67 added to existing stakes and 47 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $10.8M. The largest seller was Ontario Teachers' Pension Plan Board, exiting entirely with an estimated $12.8M sold.
- 229 institutional investors held Editas Medicine (EDIT) as of Q4 2019, up from 187 in Q3 2019.
- Funds reported $1.35B of Editas Medicine stock for Q4 2019, up 32% quarter-over-quarter.
- 64 funds opened new Editas Medicine positions in Q4 2019 and 20 closed out, a net change of +44 holders.
- The largest Editas Medicine buyer in Q4 2019 was D.E. Shaw & Co, an estimated $10.8M added.
- The largest Editas Medicine seller in Q4 2019 was Ontario Teachers' Pension Plan Board, an estimated $12.8M sold.
Based on aggregated 13F filings for Q4 2019.